NCT05533515View on ClinicalTrials.gov

Circulating Tumour Cells as Biomarkers to Predict Prostate Cancer Metastasis for Treatment Stratification of Cancer

CompletedOBSERVATIONAL
Enrollment

330

Participants

Timeline

Start Date

February 8, 2022

Primary Completion Date

March 5, 2024

Study Completion Date

March 5, 2024

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

CTC Blood Test

We will draw blood to measure the level of Circulating Tumour Cells

Trial Locations (1)

Unknown

University College London Hospitals, London

All Listed Sponsors
collaborator

University College London Hospitals

OTHER

lead

Queen Mary University of London

OTHER